Global Promacta Market Growth 2025-2031

December 2025 | 82 pages | ID: G8C147E73580EN
LP Information

Abstracts

The global Promacta market size is predicted to grow from US$ 2003 million in 2025 to US$ 1636 million in 2031; it is expected to grow at a CAGR of -3.3% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Eltrombopag is a medication that has been developed for certain conditions that lead to thrombocytopenia (abnormally low platelet counts).

The Promacta (eltrombopag) market is driven by its efficacy in treating various blood disorders, such as chronic immune thrombocytopenia (ITP) and severe aplastic anemia. As a thrombopoietin receptor agonist, Promacta stimulates platelet production, leading to increased platelet counts and improved bleeding control. The drug's ability to reduce the need for frequent platelet transfusions and enhance patient quality of life has contributed to its growing adoption. Additionally, ongoing clinical trials exploring Promacta's potential in treating other hematological conditions continue to drive market expansion. However, challenges such as potential side effects, patient affordability, and competition from other treatment options persist. Addressing these challenges through continued research, improved patient access, and effective marketing strategies will be essential for sustaining Promacta's growth in the market.

LP Information, Inc. (LPI) ' newest research report, the “Promacta Industry Forecast” looks at past sales and reviews total world Promacta sales in 2024, providing a comprehensive analysis by region and market sector of projected Promacta sales for 2025 through 2031. With Promacta sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Promacta industry.

This Insight Report provides a comprehensive analysis of the global Promacta landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Promacta portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Promacta market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Promacta and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Promacta.

This report presents a comprehensive overview, market shares, and growth opportunities of Promacta market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 25mg
• 50mg
• 75mg

Segmentation by Application:

• Hospital
• Drugs Stores
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Novartis Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Promacta market?

What factors are driving Promacta market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Promacta market opportunities vary by end market size?

How does Promacta break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Promacta Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Promacta by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Promacta by Country/Region, 2020, 2024 & 2031
2.2 Promacta Segment by Type
  2.2.1 25mg
  2.2.2 50mg
  2.2.3 75mg
2.3 Promacta Sales by Type
  2.3.1 Global Promacta Sales Market Share by Type (2020-2025)
  2.3.2 Global Promacta Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Promacta Sale Price by Type (2020-2025)
2.4 Promacta Segment by Application
  2.4.1 Hospital
  2.4.2 Drugs Stores
  2.4.3 Other
2.5 Promacta Sales by Application
  2.5.1 Global Promacta Sale Market Share by Application (2020-2025)
  2.5.2 Global Promacta Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Promacta Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Promacta Breakdown Data by Company
  3.1.1 Global Promacta Annual Sales by Company (2020-2025)
  3.1.2 Global Promacta Sales Market Share by Company (2020-2025)
3.2 Global Promacta Annual Revenue by Company (2020-2025)
  3.2.1 Global Promacta Revenue by Company (2020-2025)
  3.2.2 Global Promacta Revenue Market Share by Company (2020-2025)
3.3 Global Promacta Sale Price by Company
3.4 Key Manufacturers Promacta Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Promacta Product Location Distribution
  3.4.2 Players Promacta Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PROMACTA BY GEOGRAPHIC REGION

4.1 World Historic Promacta Market Size by Geographic Region (2020-2025)
  4.1.1 Global Promacta Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Promacta Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Promacta Market Size by Country/Region (2020-2025)
  4.2.1 Global Promacta Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Promacta Annual Revenue by Country/Region (2020-2025)
4.3 Americas Promacta Sales Growth
4.4 APAC Promacta Sales Growth
4.5 Europe Promacta Sales Growth
4.6 Middle East & Africa Promacta Sales Growth

5 AMERICAS

5.1 Americas Promacta Sales by Country
  5.1.1 Americas Promacta Sales by Country (2020-2025)
  5.1.2 Americas Promacta Revenue by Country (2020-2025)
5.2 Americas Promacta Sales by Type (2020-2025)
5.3 Americas Promacta Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Promacta Sales by Region
  6.1.1 APAC Promacta Sales by Region (2020-2025)
  6.1.2 APAC Promacta Revenue by Region (2020-2025)
6.2 APAC Promacta Sales by Type (2020-2025)
6.3 APAC Promacta Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Promacta by Country
  7.1.1 Europe Promacta Sales by Country (2020-2025)
  7.1.2 Europe Promacta Revenue by Country (2020-2025)
7.2 Europe Promacta Sales by Type (2020-2025)
7.3 Europe Promacta Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Promacta by Country
  8.1.1 Middle East & Africa Promacta Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Promacta Revenue by Country (2020-2025)
8.2 Middle East & Africa Promacta Sales by Type (2020-2025)
8.3 Middle East & Africa Promacta Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Promacta
10.3 Manufacturing Process Analysis of Promacta
10.4 Industry Chain Structure of Promacta

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Promacta Distributors
11.3 Promacta Customer

12 WORLD FORECAST REVIEW FOR PROMACTA BY GEOGRAPHIC REGION

12.1 Global Promacta Market Size Forecast by Region
  12.1.1 Global Promacta Forecast by Region (2026-2031)
  12.1.2 Global Promacta Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Promacta Forecast by Type (2026-2031)
12.7 Global Promacta Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Novartis Pharmaceuticals
  13.1.1 Novartis Pharmaceuticals Company Information
  13.1.2 Novartis Pharmaceuticals Promacta Product Portfolios and Specifications
  13.1.3 Novartis Pharmaceuticals Promacta Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Novartis Pharmaceuticals Main Business Overview
  13.1.5 Novartis Pharmaceuticals Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Promacta Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Promacta Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 25mg
Table 4. Major Players of 50mg
Table 5. Major Players of 75mg
Table 6. Global Promacta Sales by Type (2020-2025) & (K Unit)
Table 7. Global Promacta Sales Market Share by Type (2020-2025)
Table 8. Global Promacta Revenue by Type (2020-2025) & ($ million)
Table 9. Global Promacta Revenue Market Share by Type (2020-2025)
Table 10. Global Promacta Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Promacta Sale by Application (2020-2025) & (K Unit)
Table 12. Global Promacta Sale Market Share by Application (2020-2025)
Table 13. Global Promacta Revenue by Application (2020-2025) & ($ million)
Table 14. Global Promacta Revenue Market Share by Application (2020-2025)
Table 15. Global Promacta Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Promacta Sales by Company (2020-2025) & (K Unit)
Table 17. Global Promacta Sales Market Share by Company (2020-2025)
Table 18. Global Promacta Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Promacta Revenue Market Share by Company (2020-2025)
Table 20. Global Promacta Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Promacta Producing Area Distribution and Sales Area
Table 22. Players Promacta Products Offered
Table 23. Promacta Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Promacta Sales by Geographic Region (2020-2025) & (K Unit)
Table 27. Global Promacta Sales Market Share Geographic Region (2020-2025)
Table 28. Global Promacta Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Promacta Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Promacta Sales by Country/Region (2020-2025) & (K Unit)
Table 31. Global Promacta Sales Market Share by Country/Region (2020-2025)
Table 32. Global Promacta Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Promacta Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Promacta Sales by Country (2020-2025) & (K Unit)
Table 35. Americas Promacta Sales Market Share by Country (2020-2025)
Table 36. Americas Promacta Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Promacta Sales by Type (2020-2025) & (K Unit)
Table 38. Americas Promacta Sales by Application (2020-2025) & (K Unit)
Table 39. APAC Promacta Sales by Region (2020-2025) & (K Unit)
Table 40. APAC Promacta Sales Market Share by Region (2020-2025)
Table 41. APAC Promacta Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Promacta Sales by Type (2020-2025) & (K Unit)
Table 43. APAC Promacta Sales by Application (2020-2025) & (K Unit)
Table 44. Europe Promacta Sales by Country (2020-2025) & (K Unit)
Table 45. Europe Promacta Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Promacta Sales by Type (2020-2025) & (K Unit)
Table 47. Europe Promacta Sales by Application (2020-2025) & (K Unit)
Table 48. Middle East & Africa Promacta Sales by Country (2020-2025) & (K Unit)
Table 49. Middle East & Africa Promacta Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Promacta Sales by Type (2020-2025) & (K Unit)
Table 51. Middle East & Africa Promacta Sales by Application (2020-2025) & (K Unit)
Table 52. Key Market Drivers & Growth Opportunities of Promacta
Table 53. Key Market Challenges & Risks of Promacta
Table 54. Key Industry Trends of Promacta
Table 55. Promacta Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Promacta Distributors List
Table 58. Promacta Customer List
Table 59. Global Promacta Sales Forecast by Region (2026-2031) & (K Unit)
Table 60. Global Promacta Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Promacta Sales Forecast by Country (2026-2031) & (K Unit)
Table 62. Americas Promacta Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Promacta Sales Forecast by Region (2026-2031) & (K Unit)
Table 64. APAC Promacta Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Promacta Sales Forecast by Country (2026-2031) & (K Unit)
Table 66. Europe Promacta Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Promacta Sales Forecast by Country (2026-2031) & (K Unit)
Table 68. Middle East & Africa Promacta Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Promacta Sales Forecast by Type (2026-2031) & (K Unit)
Table 70. Global Promacta Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Promacta Sales Forecast by Application (2026-2031) & (K Unit)
Table 72. Global Promacta Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Novartis Pharmaceuticals Basic Information, Promacta Manufacturing Base, Sales Area and Its Competitors
Table 74. Novartis Pharmaceuticals Promacta Product Portfolios and Specifications
Table 75. Novartis Pharmaceuticals Promacta Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Novartis Pharmaceuticals Main Business
Table 77. Novartis Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Promacta
Figure 2. Promacta Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Promacta Sales Growth Rate 2020-2031 (K Unit)
Figure 7. Global Promacta Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Promacta Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Promacta Sales Market Share by Country/Region (2024)
Figure 10. Promacta Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 25mg
Figure 12. Product Picture of 50mg
Figure 13. Product Picture of 75mg
Figure 14. Global Promacta Sales Market Share by Type in 2025
Figure 15. Global Promacta Revenue Market Share by Type (2020-2025)
Figure 16. Promacta Consumed in Hospital
Figure 17. Global Promacta Market: Hospital (2020-2025) & (K Unit)
Figure 18. Promacta Consumed in Drugs Stores
Figure 19. Global Promacta Market: Drugs Stores (2020-2025) & (K Unit)
Figure 20. Promacta Consumed in Other
Figure 21. Global Promacta Market: Other (2020-2025) & (K Unit)
Figure 22. Global Promacta Sale Market Share by Application (2024)
Figure 23. Global Promacta Revenue Market Share by Application in 2025
Figure 24. Promacta Sales by Company in 2025 (K Unit)
Figure 25. Global Promacta Sales Market Share by Company in 2025
Figure 26. Promacta Revenue by Company in 2025 ($ millions)
Figure 27. Global Promacta Revenue Market Share by Company in 2025
Figure 28. Global Promacta Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Promacta Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Promacta Sales 2020-2025 (K Unit)
Figure 31. Americas Promacta Revenue 2020-2025 ($ millions)
Figure 32. APAC Promacta Sales 2020-2025 (K Unit)
Figure 33. APAC Promacta Revenue 2020-2025 ($ millions)
Figure 34. Europe Promacta Sales 2020-2025 (K Unit)
Figure 35. Europe Promacta Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Promacta Sales 2020-2025 (K Unit)
Figure 37. Middle East & Africa Promacta Revenue 2020-2025 ($ millions)
Figure 38. Americas Promacta Sales Market Share by Country in 2025
Figure 39. Americas Promacta Revenue Market Share by Country (2020-2025)
Figure 40. Americas Promacta Sales Market Share by Type (2020-2025)
Figure 41. Americas Promacta Sales Market Share by Application (2020-2025)
Figure 42. United States Promacta Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Promacta Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Promacta Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Promacta Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Promacta Sales Market Share by Region in 2025
Figure 47. APAC Promacta Revenue Market Share by Region (2020-2025)
Figure 48. APAC Promacta Sales Market Share by Type (2020-2025)
Figure 49. APAC Promacta Sales Market Share by Application (2020-2025)
Figure 50. China Promacta Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Promacta Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Promacta Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Promacta Revenue Growth 2020-2025 ($ millions)
Figure 54. India Promacta Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Promacta Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Promacta Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Promacta Sales Market Share by Country in 2025
Figure 58. Europe Promacta Revenue Market Share by Country (2020-2025)
Figure 59. Europe Promacta Sales Market Share by Type (2020-2025)
Figure 60. Europe Promacta Sales Market Share by Application (2020-2025)
Figure 61. Germany Promacta Revenue Growth 2020-2025 ($ millions)
Figure 62. France Promacta Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Promacta Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Promacta Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Promacta Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Promacta Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Promacta Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Promacta Sales Market Share by Application (2020-2025)
Figure 69. Egypt Promacta Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Promacta Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Promacta Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Promacta Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Promacta Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Promacta in 2025
Figure 75. Manufacturing Process Analysis of Promacta
Figure 76. Industry Chain Structure of Promacta
Figure 77. Channels of Distribution
Figure 78. Global Promacta Sales Market Forecast by Region (2026-2031)
Figure 79. Global Promacta Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Promacta Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Promacta Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Promacta Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Promacta Revenue Market Share Forecast by Application (2026-2031)